Literature DB >> 29705720

O-(2-(18F)fluoroethyl)-L-tyrosine PET for the differentiation of tumour recurrence from late pseudoprogression in glioblastoma.

Milena I Mihovilovic1, Olivia Kertels2, Heribert Hänscheid1, Mario Löhr3, Camelia-Maria Monoranu4, Irene Kleinlein4, Samuel Samnick1, Almuth F Kessler3, Thomas Linsenmann3, Ralf-Ingo Ernestus3, Andreas K Buck1, Constantin Lapa1.   

Abstract

Entities:  

Keywords:  neurooncology; pet, ligand studies

Year:  2018        PMID： 29705720     DOI： 10.1136/jnnp-2017-317155

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  9 in total

1.  Recurrent glioblastoma versus late posttreatment changes: diagnostic accuracy of O-(2-[18F]fluoroethyl)-L-tyrosine positron emission tomography (18F-FET PET).

Authors:  Asma Bashir; Sofie Mathilde Jacobsen; Otto Mølby Henriksen; Helle Broholm; Thomas Urup; Kirsten Grunnet; Vibeke Andrée Larsen; Søren Møller; Jane Skjøth-Rasmussen; Hans Skovgaard Poulsen; Ian Law
Journal:  Neuro Oncol       Date:  2019-12-17       Impact factor: 12.300

2.  Prognostic Value of O-(2-[18F]Fluoroethyl)-L-Tyrosine PET/CT in Newly Diagnosed WHO 2016 Grade II and III Glioma.

Authors:  Olivia Kertels; Almuth F Kessler; Milena I Mihovilovic; Antje Stolzenburg; Thomas Linsenmann; Samuel Samnick; Stephanie Brändlein; Camelia Maria Monoranu; Ralf-Ingo Ernestus; Andreas K Buck; Mario Löhr; Constantin Lapa
Journal:  Mol Imaging Biol       Date:  2019-12       Impact factor: 3.488

3.  The Value of FET PET/CT in Recurrent Glioma with a Different IDH Mutation Status: The Relationship between Imaging and Molecular Biomarkers.

Authors:  Marija Skoblar Vidmar; Andrej Doma; Uroš Smrdel; Katarina Zevnik; Andrej Studen
Journal:  Int J Mol Sci       Date:  2022-06-17       Impact factor: 6.208

4.  Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients - a report of the PET/RANO group.

Authors:  Norbert Galldiks; Maximilian Niyazi; Anca L Grosu; Martin Kocher; Karl-Josef Langen; Ian Law; Giuseppe Minniti; Michelle M Kim; Christina Tsien; Frederic Dhermain; Riccardo Soffietti; Minesh P Mehta; Michael Weller; Jörg-Christian Tonn
Journal:  Neuro Oncol       Date:  2021-06-01       Impact factor: 12.300

5.  Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression.

Authors:  Marguerite Müller; Oliver Winz; Robin Gutsche; Ralph T H Leijenaar; Martin Kocher; Christoph Lerche; Christian P Filss; Gabriele Stoffels; Eike Steidl; Elke Hattingen; Joachim P Steinbach; Gabriele D Maurer; Alexander Heinzel; Norbert Galldiks; Felix M Mottaghy; Karl-Josef Langen; Philipp Lohmann
Journal:  J Neurooncol       Date:  2022-07-19       Impact factor: 4.506

Review 6.  DEGRO practical guideline for central nervous system radiation necrosis part 1: classification and a multistep approach for diagnosis.

Authors:  Denise Bernhardt; Laila König; Anca Grosu; Benedikt Wiestler; Stefan Rieken; Wolfgang Wick; Jens Gempt; Sandro M Krieg; Friederike Schmidt-Graf; Felix Sahm; Bernhard Meyer; Bernd J Krause; Cordula Petersen; Rainer Fietkau; Michael Thomas; Frank Giordano; Andrea Wittig-Sauerwein; Jürgen Debus; Ghazaleh Tabatabai; Peter Hau; Joachim Steinbach; Stephanie E Combs
Journal:  Strahlenther Onkol       Date:  2022-08-29       Impact factor: 4.033

7.  Identify glioma recurrence and treatment effects with triple-tracer PET/CT.

Authors:  Cong Li; Chang Yi; Yingshen Chen; Shaoyan Xi; Chengcheng Guo; Qunying Yang; Jian Wang; Ke Sai; Ji Zhang; Chao Ke; Fanfan Chen; Yanchun Lv; Xiangsong Zhang; Zhongping Chen
Journal:  BMC Med Imaging       Date:  2021-05-31       Impact factor: 1.930

8.  Sequential implementation of DSC-MR perfusion and dynamic [18F]FET PET allows efficient differentiation of glioma progression from treatment-related changes.

Authors:  Eike Steidl; Karl-Josef Langen; Sarah Abu Hmeidan; Nenad Polomac; Christian P Filss; Norbert Galldiks; Philipp Lohmann; Fee Keil; Katharina Filipski; Felix M Mottaghy; Nadim Jon Shah; Joachim P Steinbach; Elke Hattingen; Gabriele D Maurer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-11-26       Impact factor: 9.236

Review 9.  Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors.

Authors:  Jan-Michael Werner; Philipp Lohmann; Gereon R Fink; Karl-Josef Langen; Norbert Galldiks
Journal:  Molecules       Date:  2020-03-24       Impact factor: 4.411
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.